Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines
- Ioana Agache
- , Claudio Rocha
- , Ana Pereira
- , Yang Song
- , Pablo Alonso-Coello
- , Ivan Solà
- , Jessica Beltran
- , Margarita Posso
- , Cezmi A. Akdis
- , Mubeccel Akdis
- , Knut Brockow
- , Tomas Chivato
- , Stefano del Giacco
- , Thomas Eiwegger
- , Kilian Eyerich
- , Ana Giménez-Arnau
- , Jan Gutermuth
- , Emma Guttman-Yassky
- , Marcus Maurer
- , Graham Ogg
- Transilvania University of Brasov
- Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau)
- Hospital Del Mar-Instituto Municipal de Asistencia Sanitaria (IMAS)
- Instituto Salud Carlos III
- University of Zurich
- Christine Kühne-Center for Allergy Research and Education
- Universidad CEU San Pablo
- University of Cagliari
- Hospital for Sick Children and University of Toronto
- University of Toronto Faculty of Medicine
- Hospital for Sick Children and University of Toronto
- Universitat Autònoma de Barcelona
- Universitair Ziekenhuis Brussel
- Mount Sinai School of Medicine
- Charité – Universitätsmedizin Berlin
- University of Oxford
- Keck School of Medicine of USC
- APC Microbiome Ireland
- University of Edinburgh
- Hannover Medical School
- Universidad Complutense de Madrid
- Wrocław University
- "ALL-MED" Medical Research Institute
Research output: Contribution to journal › Article › peer-review
87
Scopus
citations